Kynostatin-272, formerly known as KNI-272; NSC-651714; DRG-0219, is a potent HIV protease inhibitor with the potential for the treatment of HIV infection. KNI-272 blocked the maturation of viral particles. Consequently, KNI-272 has at least two inhibition targets in the stages of the HIV-1 life cycle.

纯度：≥98%

CAS：147318-81-8